<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="149575">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01784588</url>
  </required_header>
  <id_info>
    <org_study_id>U9915-Solyx</org_study_id>
    <nct_id>NCT01784588</nct_id>
  </id_info>
  <brief_title>Post Market Study Of Single Incision Sling Versus Transobturator Sling for Stress Urinary Incontinence</brief_title>
  <acronym>Solyx</acronym>
  <official_title>A Prospective, Non-Randomized, Parallel Cohort, Multi-center Study of the Solyx™ Single Incision Sling System vs. the Obtryx™ II Sling System for the Treatment of Women With Stress Urinary Incontinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <authority>Australia: Human Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to compare the treatment device (Solyx) to a different
      mesh sling or control device (Obtryx II) for the treatment of symptoms for SUI.  Safety
      information and patient outcomes will be collected for three (3) years and evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>The primary endpoint is an assessment of improvement in stress urinary incontinence at 36 months as compared to Baseline, by a composite of objective and subjective measures.</measure>
    <time_frame>36 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>The primary endpoint is an assessment of improvement in stress urinary incontinence at 36 months as compared to Baseline, by a composite of objective and subjective measures:  negative cough stress test and a subject self-reported improvement in their condition, through the Patient Global Impression of Improvement (PGI-I).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Stress Urinary Incontinence</condition>
  <arm_group>
    <arm_group_label>Solyx Single Incision Sling System</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Solyx Single Incision Sling System</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Obtryx II Sling System</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Obtryx II Sling System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Solyx Single Incision Sling System</intervention_name>
    <description>Solyx Single Incision Sling System</description>
    <arm_group_label>Solyx Single Incision Sling System</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Obtryx II Sling System</intervention_name>
    <description>to compare a single incision midurethral sling to a standard outside-in transobturator sling for the treatment of female stress urinary incontinence.</description>
    <arm_group_label>Obtryx II Sling System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Female ≥ 18 years of age

          2. Willing and able to comply with the study procedures and provide written informed
             consent to participate in the study (subject or legal representative)

          3. Diagnosed with predominant SUI confirmed by positive cough stress test during  the
             protocol required bladder fill procedure (see manual of operations)

          4. Confirmed SUI is greater than urge incontinence with MESA

          5. Cystometric capacity ≥ 300 cc

          6. Post-void residual (PVR) of ≤ 150 cc

          7. Medically approved for general, regional or monitored anesthesia

        Exclusion Criteria:

          1. Subjects who are pregnant, lactating, or planning future pregnancies

          2. Subjects with a chief complaint of overactive bladder

          3. Subjects with a pattern of recurrent urinary tract infections, defined as ≥ 2
             culture-proven urinary tract infections during a 6-month period prior to surgery or ≥
             3 in a 12-month period

          4. Subjects with previous surgical  procedures for SUI including bulking, urethral
             sling, bone anchor, Burch procedure, pubo-vaginal sling, and MMK procedure. Excluding
             Kelly plication, Botox, anterior repair, or Inter-Stim

          5. Subjects with prior pelvic organ prolapse surgery who experienced mesh complications

          6. Subjects with previous radiation therapy to the pelvis

          7. Subjects with known or suspected hypersensitivity to polypropylene mesh

          8. Subjects with any of the following confounding conditions:

               1. Neurogenic bladder

               2. Urethral stricture and bladder neck contracture

               3. Bladder stones or tumors

               4. Urinary tract fistula or diverticula

               5. Pathology which would compromise implant placement including subjects  currently
                  taking anticoagulation therapy

               6. Pathology that would limit blood supply or infections that would compromise
                  healing including chemotherapy, systemic steroids and systemic
                  immunosuppressants

          9. Subjects with diabetes and an A1c ≥ 7%

         10. Non-English speaking subjects

         11. Subjects who have participated in an investigational study (medical device or drug)
             within 30 days of study entry that may impact analysis of this device or have
             previously participated in the current study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cedars Sinai Medical Center</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Colby Perkins</last_name>
      <phone>310-385-2992</phone>
      <email>colbyperkins@mednet.ucla.edu</email>
    </contact>
    <investigator>
      <last_name>Karyn Eilber, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of CA Irvine Medical Center</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha Reiters</last_name>
      <phone>714-456-8564</phone>
      <email>reiters@uci.edu</email>
    </contact>
    <investigator>
      <last_name>Karen Noblett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loma Linda University Medical Center</name>
      <address>
        <city>Loma Linda</city>
        <state>California</state>
        <zip>92354</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carol Morgan</last_name>
      <phone>909-705-9321</phone>
    </contact>
    <investigator>
      <last_name>Sam Siddighi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Scripps Clinic Carmel Valley</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Giovanetty</last_name>
      <phone>858-764-3023</phone>
      <email>Giovanetty.nancy@scrippshealth.org</email>
    </contact>
    <investigator>
      <last_name>Bruce Kahn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Norwalk Hospital</name>
      <address>
        <city>Norwalk</city>
        <state>Connecticut</state>
        <zip>06850</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teri Jacoby</last_name>
      <phone>203-853-4200</phone>
      <phone_ext>2</phone_ext>
      <email>terijacoby@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Scott Serels, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Christiana Hospital</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Mann</last_name>
      <phone>302-733-3065</phone>
      <email>jmann@christianacare.org</email>
    </contact>
    <investigator>
      <last_name>Howard Goldstein, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Physicians Regional Healthcare</name>
      <address>
        <city>Naples</city>
        <state>Florida</state>
        <zip>34105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Wilson</last_name>
      <email>awilson485@comcast.net</email>
    </contact>
    <investigator>
      <last_name>Joseph Gauta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cherokee Women's Health Specialist</name>
      <address>
        <city>Canton</city>
        <state>Georgia</state>
        <zip>30114</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angel Bobo</last_name>
      <phone>770-720-7733</phone>
      <phone_ext>2255</phone_ext>
      <email>Angel.bobo@cherokeewomenshealth.com</email>
    </contact>
    <investigator>
      <last_name>Michael Litrel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Methodist Hospital of Indianapolis</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Chesapeake Urology Research Associates</name>
      <address>
        <city>Glen Burnie</city>
        <state>Maryland</state>
        <zip>21061</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginia Michaels</last_name>
      <phone>443-471-5753</phone>
      <email>vmichaels@cua.md</email>
    </contact>
    <investigator>
      <last_name>Kaiser Robertson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Novant Health Presbyterian Medical Center</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julie Lacourfiere</last_name>
      <email>jlacoursiere@novanthealth.org</email>
    </contact>
    <investigator>
      <last_name>William Porter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alliance Urology Specialists</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Bennett</last_name>
      <email>lbennett@allianceurology.com</email>
    </contact>
    <investigator>
      <last_name>Sigmund Tannenbaum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lyndhurst Clinical Research</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Jester</last_name>
      <phone>336-397-3723</phone>
      <email>jmjester@lyndhurstresearch@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Bradley Jacobs, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St Alexius Medical Center</name>
      <address>
        <city>Bismarck</city>
        <state>North Dakota</state>
        <zip>58501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Wetzstein</last_name>
      <phone>701-530-6960</phone>
      <email>jwetzstein@primecare.org</email>
    </contact>
    <investigator>
      <last_name>Thomas Hutchens, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Genesis Healthcare System</name>
      <address>
        <city>Zanesville</city>
        <state>Ohio</state>
        <zip>43701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michele Abernethy</last_name>
      <phone>740-450-7817</phone>
      <email>mabernethy@rrohio.com</email>
    </contact>
    <investigator>
      <last_name>Parekh Mitesh, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Pelvic Health</name>
      <address>
        <city>Franklin</city>
        <state>Tennessee</state>
        <zip>37067</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Debbie Loope</last_name>
      <phone>615-289-8183</phone>
      <email>debloope@att.net</email>
    </contact>
    <investigator>
      <last_name>Barry Jarnagin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas Southwestern</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Poppy Poth</last_name>
      <phone>512-324-9999</phone>
      <phone_ext>89612</phone_ext>
      <email>pepoth@seton.org</email>
    </contact>
    <investigator>
      <last_name>Amanda White, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Texas, Southwestern</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elva Moore</last_name>
      <phone>214-648-7211</phone>
      <email>kelly.moore@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Joseph Schaffer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor University Medical Center</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cathy Frisinger</last_name>
      <phone>817-922-2574</phone>
      <email>cathy.frisinger1@baylorhealth.edu</email>
    </contact>
    <investigator>
      <last_name>Michael England, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Female Health Associates of North Texas</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lisa Gee</last_name>
      <phone>817-888-1738</phone>
      <email>LisaGee@texashealth.org</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Hantes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Fischer</last_name>
      <phone>713-790-9779</phone>
      <email>emily.fisher@hmutx.com</email>
    </contact>
    <investigator>
      <last_name>Ricardo Gonzalez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MacArthur OB/GYN Management, LLC</name>
      <address>
        <city>Irving</city>
        <state>Texas</state>
        <zip>75062</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jai Fields</last_name>
      <phone>972-573-3293</phone>
      <email>jfields@bexarclinicaltrials.com</email>
    </contact>
    <investigator>
      <last_name>Jeffrey Livingston, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Las Colinas OBGYN</name>
      <address>
        <city>Irving</city>
        <state>Texas</state>
        <zip>75062</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annie Saldana</last_name>
      <phone>972-257-5300</phone>
      <phone_ext>114</phone_ext>
      <email>annie@lascolinasobgyn.com</email>
    </contact>
    <investigator>
      <last_name>John Zavaleta, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dr Morris Mitchell Silver</name>
      <address>
        <city>Nacogdoches</city>
        <state>Texas</state>
        <zip>75965</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kandyce Silver</last_name>
      <phone>936-371-3589</phone>
      <email>kandycesilver@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>M. Mitchell Silver, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Permian Research Foundation</name>
      <address>
        <city>Odessa</city>
        <state>Texas</state>
        <zip>79761</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alana Wood</last_name>
      <phone>432-580-9876</phone>
      <email>alana@prftx.com</email>
    </contact>
    <investigator>
      <last_name>Pill Raja, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Valley Medical Center</name>
      <address>
        <city>Renton</city>
        <state>Washington</state>
        <zip>98055</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Denise Richmond</last_name>
      <phone>425-228-0722</phone>
      <email>drichmond.vwcresearch@gmail.com</email>
    </contact>
    <investigator>
      <last_name>James Rice, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cabrini Medical Centre</name>
      <address>
        <city>Malvern</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Elizabeth Fitzgerald</last_name>
      <phone>+61 3 9509 6500</phone>
      <email>annarosamilia@urogyn.com.au</email>
    </contact>
    <investigator>
      <last_name>Anna Rosamilia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
    <country>Australia</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 13, 2014</lastchanged_date>
  <firstreceived_date>February 4, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Urinary Incontinence, Stress</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
